Showing results (111-120 of 138) with videos related to
Sort By:
Pageof 14
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|April 21, 2025
Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohortNicole Reis, Omar Sued, Tarsila Vieceli, et al.Health Research Policy and Systems|February 10, 2018
ISRIA statement: ten-point guidelines for an effective process of research impact assessmentPaula Adam, Pavel V Ovseiko, Jonathan Grant, et al.Enfermedades Infecciosas Y Microbiologia Clinica|May 27, 2006
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003)Omar Sued, José M Miró, Aitor Alquezar, et al.Journal of the International AIDS Society|August 12, 2011
Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconvertersM Eugenia Socías, Omar Sued, Natalia Laufer, et al.Plos One|June 10, 2010
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin AmericaCarina Cesar, Bryan E Shepherd, Alejandro J Krolewiecki, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2008
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain)Angeles Jaén, Anna Esteve, Josep M Miró, et al.Medicina Clinica|April 26, 2005
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project]Angeles Jaén, Jordi Casabona, Anna Esteve, et al.The Journal of Antimicrobial Chemotherapy|November 18, 2024
Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22Francis Morey, Amalia Girón-Callejas, Russell Manzanero, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2016
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trialDavid Nicolás, Juan Ambrosioni, Omar Sued, et al.Plos One|October 23, 2013
Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screeningLukas Fenner, Marie Ballif, Claire Graber, et al.Pageof 14